About Contact Us Careers

HIV Drugs Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 162
Published Date: Sep 05, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the HIV Drugs Landscape

Merck & Co., Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Boehringer Ingelheim International GmbH
Gilead Sciences, Inc.
GlaxoSmithKline plc.
F. Hoffmann-La Roche Ltd.
Cipla Inc.
Teva Pharmaceuticals Industries Ltd.
Janssen Global Services, LLC
Mylan N.V.
AbbVie Inc.

Browse Key Market Insights with Data Illustration:

HIV Drugs Market Size | Growth Forecast Report 2036

In the News

March 23, 2020: Gilead affirms that its supply chain is resilient even in the pandemic and does not see shortages of HIV treatment or prevention medicines in the future.

Author Credits: Radhika Pawar

Report ID: 162
Published Date: Sep 05, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of HIV drugs is evaluated at USD 36.3 billion.

HIV Drugs Market size was valued at USD 34.61 billion in 2023 and is set to cross USD 74.73 billion by 2036, registering more than 6.1% CAGR during the forecast period i.e., between 2024-2036. The surging AIDS cases worldwide will impel the market growth.

North America is likely to dominate majority revenue share by 2036, on the back of presence of an ultra-modern healthcare system.

The major players in the market are F. Hoffmann-La Roche Ltd, Cipla Inc., Teva Pharmaceuticals Industries Ltd. and Janssen Global Services, LLC.

Inquiry Before Buying Request Free Sample